Supplementary Figure. Genomic Structure of nOPV2-c1 Vaccine Strain With Genetic Modifications Responsible for Attenuation, Increased Genetic Stability and Reduced Potential for Recombination Engineered in nOPV2 and Location of Key Mutations and Recombination Junctions§ Identified in nOPV2 Isolates

Details

• Alternative Title:
  Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021: Supplementary Figure. Genomic Structure of nOPV2-c1 Vaccine Strain With Genetic Modifications Responsible for Attenuation, Increased Genetic Stability and Reduced Potential for Recombination Engineered in nOPV2 and Location of Key Mutations and Recombination Junctions§ Identified in nOPV2 Isolates
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2022; v. 71, no. 24
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pages in Document:
  1 pdf page
• Volume:
  71
• Issue:
  24
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:620320259eeb02e2e45d686b2100492ba1bc4c278136b627a9a53ed0f4a2ff4b1937943a38e5e82a463fc88d97e0eb9a3b4e4669338856f5da5b2e8c9e49cfa0
• Download URL:
  https://stacks.cdc.gov/view/cdc/118054/cdc_118054_DS1.pdf
• File Type:
  [PDF - 228.87 KB ]